Janux Therapeutics, Inc. (JANX)

Janux Therapeutics Stock Forecast

Stock Price Forecast

The 12 analysts that cover Janux Therapeutics stock have a consensus rating of "Buy" and an average price target of $47, which forecasts a 223.25% increase in the stock price over the next year. The lowest target is $12 and the highest is $100.

Price Target: $47 (+223.25%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$12	$47	$45	$100
Change	-17.47%	+223.25%	+209.49%	+587.76%

Analyst Ratings

The average analyst rating for Janux Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	6	5	5	5	6	6
Buy	4	4	4	4	3	3
Hold	2	3	3	3	3	3
Sell	0	0	0	0	1	1
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Boris Peaker Jones Trading	Jones Trading	Strong Buy Maintains $50 → $28	Strong Buy	Maintains	$50 → $28	+92.57%	Apr 28, 2026
Etzer Darout Barclays	Barclays	Buy → Sell Downgrades $29 → $14	Buy → Sell	Downgrades	$29 → $14	-3.71%	Apr 20, 2026
David Dai UBS	UBS	Strong Buy → Hold Downgrades $57 → $15	Strong Buy → Hold	Downgrades	$57 → $15	+3.16%	Apr 15, 2026
Josh Schimmer Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $150 → $100	Buy	Maintains	$150 → $100	+587.76%	Feb 27, 2026
Brad Canino Guggenheim	Guggenheim	Strong Buy Maintains $72 → $68	Strong Buy	Maintains	$72 → $68	+367.68%	Feb 27, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

11.84M

Increased by 18.39%

from 10.00M

Revenue Next Year

6.17M

Decreased by -47.88%

from 11.84M

EPS This Year

-2.53

from -1.83

EPS Next Year

-3.38

from -2.53

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	3.64M	8.61M	8.08M	10.59M	10.00M	11.84M	6.17M
Revenue Growth	-	136.79%	-6.14%	30.99%	-5.55%	18.39%	-47.88%
EPS	-1.39	-1.52	-1.32	-1.28	-1.83	-2.53	-3.38
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	20	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	60.4M	36.8M
Avg	11.8M	6.2M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	503.7%	210.4%
Avg	18.4%	-47.9%
Low	-	-

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	-1.73	-2.37
Avg	-2.53	-3.38
Low	-3.22	-5.84

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.